- July 5, 2018 | BY
From Dublin to Delaware, two experts in microbial detection offer guidance on how companies can ensure their EM programs are working efficiently
- July 2, 2018 | BY
UK researchers are using an MS drug to target the root causes of this devastating psychiatric disorder
- June 29, 2018 | BY
Promising updates on an experimental treatment for glioblastoma, are you sabotaging your sun safety, and can CRISPR reduce exaggerated repetitive behavior?
- June 28, 2018 | BY
A high-resolution image of Zika offers unprecedented detail of the surface of the flavivirus. Could the information lead us to a vaccine or therapeutics?
- June 25, 2018 | BY
When assessing the safety of their drug candidates, pharmaceutical companies should think about testing them for ototoxicity
- June 22, 2018 | BY
Addressing a public concern over technology abuse, another reason why the obese should work out, and a new breakthrough discovery to treat Alzheimer’s disease.
- June 20, 2018 | BY
Galleria mellonella as an infection model system is a cost-effective way to help combat antimicrobial resistance
- June 19, 2018 | BY
The future of CNS research is predicated on an alignment of preclinical and clinical endpoints
- June 18, 2018 | BY
Five points to help genotype genetically modified animals and ensure the genetic integrity of breeding colonies
- June 15, 2018 | BY
A potential new drug therapy for spinal cord injuries, a fun way to explain DNA recombination and some interesting scientific studies behind the 2018 World Cup.